Form 8-K - Current report:
SEC Accession No. 0000950170-25-047701
Filing Date
2025-03-31
Accepted
2025-03-31 16:07:39
Documents
13
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20250331.htm   iXBRL 8-K 44503
2 EX-99.1 rani-ex99_1.htm EX-99.1 233243
3 GRAPHIC img125106939_0.jpg GRAPHIC 83479
  Complete submission text file 0000950170-25-047701.txt   524208

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20250331.xsd EX-101.SCH 26034
15 EXTRACTED XBRL INSTANCE DOCUMENT rani-20250331_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 25793227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)